KAMA AUSBORN: Open Payments
NPI 1669056123 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,728 in 80 payments from 17 companies in 2025. Trend: 2023 $33,012 · 2024 $18,206 · 2025 $10,728
Speaker / faculty: $4,830Consulting: $3,710Food & beverage: $1,325Travel & lodging: $863
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 27 | $9,907 |
| Axsome Therapeutics, Inc. | 15 | $220 |
| Otsuka America Pharmaceutical, Inc. | 14 | $173 |
| ABBVIE INC. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Lundbeck LLC | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $20 |
Products named: LYBALVI, Auvelity, REXULTI, ARISTADA, VRAYLAR, CAPLYTA, INGREZZA, COBENFY.
Industry payments across IA — which companies pay providers there.
